Stock Earnings Crinetics Pharmaceuticals Inc [CRNX] Shares Fall Approximately -41.72% Over the Year Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Crinetics Pharmaceuticals
Analysts Viewpoint Crinetics Pharmaceuticals Inc [CRNX] Stock sold by Insider Betz Stephen F. for $3.14 million Crinetics Pharmaceuticals Inc’s recently made public that its Chief Scientific Officer Betz Stephen F. unloaded Company’s shares for reported $3.14
Insiders Updates Rise in CRNX’s short interest indicates Bearish sentiment The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Stock Earnings CRNX short interest jump by 3.67%, reflecting negative sentiment The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or